Merkel Cell Carcinoma Market Is Anticipated to Witness High Growth Owing to Immunotherapeutic Advances
The Merkel cell carcinoma market encompasses a range of diagnostic tools and therapeutic agents targeting an aggressive skin cancer subtype characterized by rapid growth and high metastatic potential. Key products include immunotherapies such as PD-1 and PD-L1 inhibitors, oncolytic viruses, and emerging targeted small molecules. These treatments offer improved efficacy and safety profiles...
0 Comments 0 Shares 99 Views 0 Reviews